Valuation : Etropal AD

Market Cap 22.54M 13.55M 11.53M 10.73M 10.09M 18.55M 1.29B 18.67M 128M 49.96M 645M 50.87M 49.77M 2.14B P/E 2023
-129x
P/E 2024 247x
Enterprise Value 26.61M 16M 13.61M 12.67M 11.91M 21.89M 1.52B 22.04M 152M 58.98M 762M 60.06M 58.75M 2.53B EV / Sales 2023
2.42x
EV / Sales 2024 1.63x
Free-Float
48.99%
Yield 2023 *
-
Yield 2024 -
1 day-1.50%
1 week-1.50%
1 month-5.07%
3 months+13.91%
6 months+13.91%
Current year+14.03%
1 week 2.1
Extreme 2.1
2.66
1 month 2.1
Extreme 2.1
2.66
Current year 2.1
Extreme 2.1
2.76
1 year 2.04
Extreme 2.044493
2.76
3 years 1.94
Extreme 1.935661
2.76
5 years 1.94
Extreme 1.935661
3.48
10 years 0.51
Extreme 0.511256
3.48
Manager TitleAgeSince
Chief Executive Officer - 01/01/1998
Investor Relations Contact - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member - 01/01/1998
Director/Board Member - 01/01/2007
Chairman - 04/12/2014
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-1.50%+25.45%+2.53% 15.21M
+2.31%+1.49%-23.40%-40.22% 16.05B
+4.03%+19.54%+56.55%+168.07% 5.32B
-0.43%-1.14%+234.77%+205.71% 3.2B
+1.56%+4.98%-29.39%-29.29% 2.52B
-0.13%+1.22%-31.55%-26.37% 1.82B
-3.79%-4.51%+8.55%-16.99% 1.31B
-0.84%+0.42%+4.76%-17.74% 1.04B
+5.77%+11.77%+12.08%+19.23% 970M
+5.22%-8.49%+126.71%+159.50% 968M
Average +1.22%+0.26%+38.45%+42.44% 3.32B
Weighted average by Cap. +1.98%+0.75%+20.99%+27.66%

Financials

2023 2024
Net sales 11.2M 6.73M 5.73M 5.33M 5.01M 9.21M 639M 9.27M 63.8M 24.82M 321M 25.27M 24.73M 1.06B 15.75M 9.47M 8.05M 7.5M 7.05M 12.95M 899M 13.04M 89.71M 34.9M 451M 35.54M 34.77M 1.49B
Net income -28K -16.83K -14.32K -13.33K -12.54K -23.04K -1.6M -23.19K -160K -62.06K -802K -63.19K -61.82K -2.66M 87K 52.3K 44.48K 41.42K 38.95K 71.58K 4.97M 72.04K 496K 193K 2.49M 196K 192K 8.26M
Net Debt 4.08M 2.45M 2.09M 1.94M 1.83M 3.36M 233M 3.38M 23.23M 9.04M 117M 9.2M 9M 387M 4.07M 2.45M 2.08M 1.94M 1.82M 3.35M 232M 3.37M 23.18M 9.02M 116M 9.18M 8.98M 386M
Logo Etropal AD
Etropal AD is a Bulgaria-based company, which specializes in the scientific research, experimental and development activities in the field of orthopedics and traumatology. The Company manufactures and offers endoprothesys and implants, special bioceramic materials and alloys for the medicine, special surgical instruments, osteosynthesys means, single use syringes, haemodialysis apparatuses and lines and single use medical materials. The Company’s product portfolio includes fiber dialyzers, arterial and venous lines for haemodialysis, transfusion and infusion sets, fistula and injection needles, catheters, tubes, and femoral implants, among others. The Company operates through one subsidiary, Etropal Trade OOD. As of December 31, 2011, the Company’s major shareholder was Sintetika AD with a stake of 66.53%.
Employees
100
Date Price Change Volume
31/08/26 €2.620 -1.50% 90
26/08/26 €2.660 -.--% 20
25/08/26 €2.660 -.--% 40